skip to main content

S. 1367: United States Pharmaceutical Supply Chain Review Act


We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Apr 26, 2021.


United States Pharmaceutical Supply Chain Review Act

This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.